Pharmacokinetics of trastuzumab emtansine (T-DM1) as a single agent or in combination with pertuzumab in HER2-positive breast cancer patients with recurrent or locally advanced metastatic breast cancer

被引：0
|
作者：
Dan Lu
Chunze Li
Matthew Riggs
Daniel Polhamus
Jonathan French
Priya Agarwal
Shang-Chiung Chen
Shweta Vadhavkar
Monika Patre
Alexander Strasak
Angelica Quartino
Jin Yan Jin
Sandhya Girish
机构：
[1] Genentech,Department of Clinical Pharmacology
[2] Inc.,undefined
[3] Metrum Research Group,undefined
[4] F. Hoffmann-La Roche Ltd.,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 84卷
关键词：
Trastuzumab emtansine (T-DM1); HER2; Pharmacokinetics; Previously untreated metastatic breast cancer; MARIANNE;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：175 / 185
页数：10
相关论文
共 50 条
  • [21] Ado-trastuzumab Emtansine (T-DM1): An Antibody-Drug Conjugate (ADC) for HER2-Positive Breast Cancer
    Lambert, John M.
    Chari, Ravi V. J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (16) : 6949 - 6964
  • [22] mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer
    Casadevall, David
    Hernandez-Prat, Anna
    Garcia-Alonso, Sara
    Arpi-Llucia, Oriol
    Menendez, Silvia
    Qin, Mengjuan
    Guardia, Cristina
    Morancho, Beatriz
    Sanchez-Martin, Francisco Javier
    Zazo, Sandra
    Gavilan, Elena
    Sabbaghi, Mohammad A.
    Eroles, Pilar
    Cejalvo, Juan Miguel
    Lluch, Ana
    Rojo, Federico
    Pandiella, Atanasio
    Rovia, Ana
    Anabell, Joan
    MOLECULAR CANCER RESEARCH, 2022, 20 (07) : 1108 - 1121
  • [23] Safety Evaluation of Trastuzumab Emtansine in Japanese Patients with HER2-Positive Advanced Breast Cancer
    Watanabe, Junichiro
    Ito, Yoshinori
    Saeki, Toshiaki
    Masuda, Norikazu
    Takano, Toshimi
    Takao, Shintaro
    Nakagami, Kazuhiko
    Tsugawa, Koichiro
    Nakagawa, Shintaro
    Kanatani, Kazumitsu
    Nakayama, Takahiro
    IN VIVO, 2017, 31 (03): : 493 - 500
  • [24] Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer
    Ma, Bo
    Ma, Qianqian
    Wang, Hongqiang
    Zhang, Guolei
    Zhang, Huiying
    Wang, Xiaohong
    ONCOTARGETS AND THERAPY, 2016, 9 : 959 - 976
  • [25] Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity
    Ajgal, Z.
    de Percin, S.
    Dieras, V.
    Pierga, J. Y.
    Campana, F.
    Fourquet, A.
    Kirova, Y. M.
    CANCER RADIOTHERAPIE, 2017, 21 (02): : 114 - 118
  • [26] T-DM1 as a New Treatment Option for Patients with Metastatic HER2-positive Breast Cancer in Clinical Practice
    Michel, Laura L.
    Bermejo, Justo Lorenzo
    Gondos, Adam
    Marme, Frederik
    Schneeweiss, Andreas
    ANTICANCER RESEARCH, 2015, 35 (09) : 5085 - 5090
  • [27] Activity of T-DM1 in Her2-positive breast cancer brain metastases
    Bartsch, Rupert
    Berghoff, Anna S.
    Vogl, Ursula
    Rudas, Margaretha
    Bergen, Elisabeth
    Dubsky, Peter
    Dieckmann, Karin
    Pinker, Katja
    Bago-Horvath, Zsuzsanna
    Galid, Arik
    Oehler, Leopold
    Zielinski, Christoph C.
    Gnant, Michael
    Steger, Guenther G.
    Preusser, Matthias
    CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (07) : 729 - 737
  • [28] Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer
    Luo, Yang
    Li, Wei
    Jiang, Zefei
    Zhang, Qingyuan
    Wang, Liwei
    Mao, Yixiang
    Tjan-Heijnen, Vivianne C. G.
    Im, Seock-Ah
    McConnell, Robin
    Bejarano, Sara
    Fumagalli, Debora
    Bines, Jose
    Wang, Bei
    Garg, Amit
    Kirschbrown, Whitney P.
    Xu, Binghe
    ANTI-CANCER DRUGS, 2019, 30 (08) : 866 - 872
  • [29] Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer
    Oostra, Drew R.
    Macrae, Erin R.
    BREAST CANCER-TARGETS AND THERAPY, 2014, 6 : 103 - 113
  • [30] Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experience
    Okines, Alicia
    Irfan, Tazia
    Khabra, Komel
    Smith, Ian
    O'Brien, Mary
    Parton, Marina
    Noble, Jill
    Stanway, Susie
    Somaiah, Navita
    Ring, Alistair
    Johnston, Stephen
    Turner, Nicholas
    BREAST JOURNAL, 2018, 24 (03): : 253 - 259
12345